EMAIL DISCLAIMER
 
Dear Visitor,
 
Please do not send any confidential information to us. By clicking “Accept,” you acknowledge and agree that our review of the information in your email and any attachments does not establish an attorney-client relationship between you and our firm or any of our attorneys, and does not preclude our representation of other persons/parties in matters where the information is pertinent, even if the information is highly confidential or could be exploited to your disadvantage, or you submitted it in good faith to retain us.
團隊
Home >> Practices >> Patent Search, Patent Validity and Infringement Assessment >> Joyce Liou
劉君怡 Joyce Liou

Joyce Liou

Counselor

聯絡方式

Joyce Liou was graduated from National Taiwan University, and obtained double bachelor degrees in Zoology and Veterinary Medicine. After two years of practice and two years of doctoral study in veterinary medicine, Joyce focused her study in data analysis and obtained her Master degree in Bioinformatics at University of Manchester, UK. During her career as bioinformatics analyst in a Biotech company, Joyce noticed the importance of patents, and decided to join Lee and Li as a patent engineer in the Chemical Group of the Patent and Technology Department, and passed the Taiwan patent bar exam in 2008 and China patent bar exam in 2011. Joyce has extensive experience in patent prosecution, patent search, patent term extension, patent invalidation actions, administrate remedy procedures and patent infringement suits, especially in pharmaceutical and biotech fields, and won the first patent linkage litigation in Taiwan in 2020.

學歷

專業領域

Patent prosecution and strategy consultation; Patent-related administrative appeal and administrative suit

經歷

Bioinformatics Analyst, DigiGenomics Co., Ltd.
Veterinarian, Chung-Sun Animal Hospital

資格

China Patent Attorney qualification (2012)
Taiwan Patent Attorney (2009)
Taiwan Veterinarian Certificate (1996)

語言

2023 Taipei High Administrative Court's Latest Ruling: Patent Information of "Category II New Drugs" Allowed to be Submitted in Patent Linkage Registration System
LEXOLOGY
2022 Taipei High Administrative Court's Latest Ruling: Patent Information of "Category II New Drugs" Allowed to be Submitted in Patent Linkage Registration System
LEXOLOGY

2023 Latest development of the patent term extension—court case law and TIPO's practice | Speaker
International Research-Based Pharmaceutical Manufacturers Association(IRPMA), Lee and Li, Attorneys-at-Law, Lee and Li Foundation
回上一頁